标题
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
作者
关键词
-
出版物
Science Translational Medicine
Volume 14, Issue 655, Pages -
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2022-07-28
DOI
10.1126/scitranslmed.abn3715
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters
- (2022) Rana Abdelnabi et al. ANTIVIRAL RESEARCH
- Three-dose vaccination elicits neutralising antibodies against omicron
- (2022) Mary Wu et al. LANCET
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
- (2022) Raquel Viana et al. NATURE
- SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
- (2022) Peter J. Halfmann et al. NATURE
- Towards SARS-CoV-2 serotypes?
- (2022) Etienne Simon-Loriere et al. NATURE REVIEWS MICROBIOLOGY
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
- (2022) Anna L. McNaughton et al. JCI Insight
- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- The antigenic anatomy of SARS-CoV-2 receptor binding domain
- (2021) Wanwisa Dejnirattisai et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Neutralizing Activity of BNT162b2-Elicited Serum
- (2021) Yang Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
- (2021) Meghan E. Garrett et al. CELL
- Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
- (2021) Venkata Viswanadh Edara et al. Cell Host & Microbe
- Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
- (2021) Carl Graham et al. IMMUNITY
- Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
- (2021) William R. Morgenlander et al. JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
- (2021) Victoria Jane Hall et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
- (2021) Kevin O. Saunders et al. NATURE
- Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
- (2021) Sandile Cele et al. NATURE
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Structural basis for broad coronavirus neutralization
- (2021) Maximilian M. Sauer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model
- (2021) Denicar Lina Nascimento Fabris Maeda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
- (2021) William N. Voss et al. SCIENCE
- Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
- (2021) Ge Song et al. Nature Communications
- A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
- (2021) Chunyan Wang et al. Nature Communications
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
- (2021) Alexandra C. Walls et al. CELL
- An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
- (2021) Yafei Liu et al. CELL
- SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
- (2021) Fatima Amanat et al. CELL
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC
- (2021) Emma C Wall et al. LANCET
- Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
- (2021) Moriah Bergwerk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
- (2021) Stacey A. Lapp et al. PLoS One
- Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques
- (2021) Hannah A. D. King et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
- (2021) David R. Martinez et al. SCIENCE
- Broad betacoronavirus neutralization by a stem helix–specific human antibody
- (2021) Dora Pinto et al. SCIENCE
- Immunological imprinting of the antibody response in COVID-19 patients
- (2021) Teresa Aydillo et al. Nature Communications
- Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern
- (2021) Donal T. Skelly et al. Nature Communications
- The landscape of antibody binding in SARS-CoV-2 infection
- (2021) Anna S. Heffron et al. PLOS BIOLOGY
- Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
- (2021) Nikhil Faulkner et al. eLife
- Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
- (2021) Paulina Kaplonek et al. Science Immunology
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Stabilized coronavirus spike stem elicits a broadly protective antibody
- (2021) Ching-Lin Hsieh et al. Cell Reports
- A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge
- (2021) Kathryn McGuckin Wuertz et al. npj Vaccines
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
- (2020) Stephen M. Kissler et al. SCIENCE
- Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers
- (2020) Catherine F Houlihan et al. LANCET
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- (2020) Anna Z. Wec et al. SCIENCE
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Kinetics of viral load and antibody response in relation to COVID-19 severity
- (2020) Yanqun Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Seasonal coronavirus protective immunity is short-lasting
- (2020) Arthur W. D. Edridge et al. NATURE MEDICINE
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
- (2020) Phuong Nguyen-Contant et al. mBio
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
- (2020) Tomer Zohar et al. CELL
- Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
- (2020) Xiancai Ma et al. IMMUNITY
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune evasion of Plasmodium falciparum by RIFIN via inhibitory receptors
- (2017) Fumiji Saito et al. NATURE
- Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
- (2012) Hatem A. Elshabrawy et al. PLoS One
- Re-Engaging Cross-Reactive Memory B Cells: The Influenza Puzzle
- (2012) Ali H. Ellebedy et al. Frontiers in Immunology
- The dominance of human coronavirus OC43 and NL63 infections in infants
- (2011) Ronald Dijkman et al. JOURNAL OF CLINICAL VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now